| UniProt ID | ZRAN1_HUMAN | |
|---|---|---|
| UniProt AC | Q9UGI0 | |
| Protein Name | Ubiquitin thioesterase ZRANB1 | |
| Gene Name | ZRANB1 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 708 | |
| Subcellular Localization | Cytoplasm. Nucleus. Enriched in punctate localization in the cytoplasm. | |
| Protein Description | Specifically hydrolyzes 'Lys-29'-linked and 'Lys-33'-linked diubiquitin. Also cleaves 'Lys-63'-linked chains, but with 40-fold less efficiency compared to 'Lys-29'-linked ones. Positive regulator of the Wnt signaling pathway that deubiquitinates APC protein, a negative regulator of Wnt-mediated transcription. Plays a role in the regulation of cell morphology and cytoskeletal organization. Required in the stress fiber dynamics and cell migration. May also modulate TNF-alpha signaling.. | |
| Protein Sequence | MSERGIKWACEYCTYENWPSAIKCTMCRAQRPSGTIITEDPFKSGSSDVGRDWDPSSTEGGSSPLICPDSSARPRVKSSYSMENANKWSCHMCTYLNWPRAIRCTQCLSQRRTRSPTESPQSSGSGSRPVAFSVDPCEEYNDRNKLNTRTQHWTCSVCTYENWAKAKRCVVCDHPRPNNIEAIELAETEEASSIINEQDRARWRGSCSSGNSQRRSPPATKRDSEVKMDFQRIELAGAVGSKEELEVDFKKLKQIKNRMKKTDWLFLNACVGVVEGDLAAIEAYKSSGGDIARQLTADEVRLLNRPSAFDVGYTLVHLAIRFQRQDMLAILLTEVSQQAAKCIPAMVCPELTEQIRREIAASLHQRKGDFACYFLTDLVTFTLPADIEDLPPTVQEKLFDEVLDRDVQKELEEESPIINWSLELATRLDSRLYALWNRTAGDCLLDSVLQATWGIYDKDSVLRKALHDSLHDCSHWFYTRWKDWESWYSQSFGLHFSLREEQWQEDWAFILSLASQPGASLEQTHIFVLAHILRRPIIVYGVKYYKSFRGETLGYTRFQGVYLPLLWEQSFCWKSPIALGYTRGHFSALVAMENDGYGNRGAGANLNTDDDVTITFLPLVDSERKLLHVHFLSAQELGNEEQQEKLLREWLDCCVTEGGVLVAMQKSSRRRNHPLVTQMVEKWLDRYRQIRPCTSLSDGEEDEDDEDE | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 35 | Phosphorylation | RAQRPSGTIITEDPF CCCCCCCCEEECCCC | 17.34 | 22617229 | |
| 38 | Phosphorylation | RPSGTIITEDPFKSG CCCCCEEECCCCCCC | 30.41 | 22617229 | |
| 43 | Ubiquitination | IITEDPFKSGSSDVG EEECCCCCCCCCCCC | 60.33 | 27667366 | |
| 69 | Ubiquitination | SSPLICPDSSARPRV CCCCCCCCCCCCCCC | 51.30 | 27667366 | |
| 77 | Ubiquitination | SSARPRVKSSYSMEN CCCCCCCCCCCCCCC | 34.66 | 23000965 | |
| 78 | Phosphorylation | SARPRVKSSYSMENA CCCCCCCCCCCCCCC | 31.48 | - | |
| 86 | Ubiquitination | SYSMENANKWSCHMC CCCCCCCCCCEEEHH | 58.89 | 27667366 | |
| 103 | Ubiquitination | LNWPRAIRCTQCLSQ CCCHHHHHHHHHHHH | 19.22 | 23000965 | |
| 105 | Phosphorylation | WPRAIRCTQCLSQRR CHHHHHHHHHHHHCC | 16.68 | 26074081 | |
| 109 | Phosphorylation | IRCTQCLSQRRTRSP HHHHHHHHHCCCCCC | 29.30 | 26074081 | |
| 113 | Phosphorylation | QCLSQRRTRSPTESP HHHHHCCCCCCCCCC | 37.37 | 28985074 | |
| 115 | Phosphorylation | LSQRRTRSPTESPQS HHHCCCCCCCCCCCC | 35.24 | 30576142 | |
| 117 | Phosphorylation | QRRTRSPTESPQSSG HCCCCCCCCCCCCCC | 50.79 | 30576142 | |
| 119 | Phosphorylation | RTRSPTESPQSSGSG CCCCCCCCCCCCCCC | 30.62 | 28348404 | |
| 122 | Phosphorylation | SPTESPQSSGSGSRP CCCCCCCCCCCCCCC | 39.80 | 30576142 | |
| 123 | Phosphorylation | PTESPQSSGSGSRPV CCCCCCCCCCCCCCE | 31.56 | 30576142 | |
| 125 | Phosphorylation | ESPQSSGSGSRPVAF CCCCCCCCCCCCEEE | 35.23 | 30576142 | |
| 127 | Phosphorylation | PQSSGSGSRPVAFSV CCCCCCCCCCEEEEE | 34.80 | 30576142 | |
| 206 | Phosphorylation | DRARWRGSCSSGNSQ HHHHHCCCCCCCCCC | 11.40 | - | |
| 208 | Phosphorylation | ARWRGSCSSGNSQRR HHHCCCCCCCCCCCC | 42.87 | - | |
| 209 | Phosphorylation | RWRGSCSSGNSQRRS HHCCCCCCCCCCCCC | 46.45 | - | |
| 212 | Phosphorylation | GSCSSGNSQRRSPPA CCCCCCCCCCCCCCC | 28.70 | - | |
| 216 | Phosphorylation | SGNSQRRSPPATKRD CCCCCCCCCCCCCCC | 37.11 | 26657352 | |
| 220 | Ubiquitination | QRRSPPATKRDSEVK CCCCCCCCCCCCCCC | 32.17 | 27667366 | |
| 227 | Ubiquitination | TKRDSEVKMDFQRIE CCCCCCCCCCHHHHH | 28.80 | 33845483 | |
| 250 | Ubiquitination | EELEVDFKKLKQIKN HHHHCCHHHHHHHHH | 53.37 | 32015554 | |
| 260 | Acetylation | KQIKNRMKKTDWLFL HHHHHHHHHCCHHHH | 49.65 | - | |
| 336 | Phosphorylation | AILLTEVSQQAAKCI HHHHHHHHHHHHHHC | 15.44 | 22210691 | |
| 546 | Ubiquitination | VYGVKYYKSFRGETL EEEEEEEHHHCCCCC | 39.77 | 27667366 | |
| 552 | Phosphorylation | YKSFRGETLGYTRFQ EHHHCCCCCCEEEEE | 28.45 | 24719451 | |
| 555 | Phosphorylation | FRGETLGYTRFQGVY HCCCCCCEEEEECEE | 9.61 | - | |
| 556 | Phosphorylation | RGETLGYTRFQGVYL CCCCCCEEEEECEEH | 24.18 | - | |
| 572 | Ubiquitination | LLWEQSFCWKSPIAL EEEECEECCCCCCCC | 5.61 | 27667366 | |
| 575 | Phosphorylation | EQSFCWKSPIALGYT ECEECCCCCCCCCCC | 9.31 | 29523821 | |
| 581 | Phosphorylation | KSPIALGYTRGHFSA CCCCCCCCCCCCHHE | 8.30 | 29523821 | |
| 582 | Phosphorylation | SPIALGYTRGHFSAL CCCCCCCCCCCHHEE | 28.51 | 29523821 | |
| 694 | Phosphorylation | YRQIRPCTSLSDGEE HHHHCCCCCCCCCCC | 35.07 | 28102081 | |
| 695 | Phosphorylation | RQIRPCTSLSDGEED HHHCCCCCCCCCCCC | 32.37 | 28102081 | |
| 697 | Phosphorylation | IRPCTSLSDGEEDED HCCCCCCCCCCCCCC | 43.25 | 30576142 |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of ZRAN1_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ZRAN1_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-260, AND MASS SPECTROMETRY. | |